Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042109 (
urticaria
)
6,569
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Paenibacillus larvae
is the causative agent of American foulbrood (AFB) disease which affects early larval stages during honeybee development. Due to its virulence, transmissibility, capacity to develop antibiotic resistance, and the inherent resilience of its endospores,
Paenibacillus larvae
is extremely difficult to eradicate from infected
hives
which often must be burned. AFB contributes to the worldwide decline of honeybee populations, which are crucial for pollination and the food supply. We have isolated a novel bacteriophage lysin, PlyPalA, from the genome of a novel
Paenibacillus larvae
bacteriophage originally extracted from an environmental sample. PlyPalA has an N-terminal
N-acetylmuramoyl-L-alanine amidase
catalytic domain and possesses lytic activity against infectious strains of
Paenibacillus larvae
without harming commensal bacteria known to compose the honeybee larval microbiota. A single dose of PlyPalA rescued 75% of larvae infected with endospores, showing that it represents a powerful tool for future treatment of AFB. This represents the first time that lysins have been tested for therapeutic use in invertebrates.
...
PMID:Isolation and characterization of a novel phage lysin active against
Paenibacillus larvae
, a honeybee pathogen. 2690 79